Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - EPA:COVH - FR0000060303 - REIT

23.4 EUR
+0.4 (+1.74%)
Last: 10/29/2025, 7:00:00 PM
Fundamental Rating

4

COVH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Diversified REITs industry. Both the profitability and the financial health of COVH get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, COVH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
COVH had a positive operating cash flow in the past year.
In multiple years COVH reported negative net income over the last 5 years.
In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

COVH has a Return On Assets (2.89%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 5.88%, COVH is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.68%, COVH is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COVH is in line with the industry average of 3.49%.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

COVH's Profit Margin of 78.96% is amongst the best of the industry. COVH outperforms 87.50% of its industry peers.
In the last couple of years the Profit Margin of COVH has declined.
With an excellent Operating Margin value of 101.55%, COVH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
COVH's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
COVH has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for COVH has been increased compared to 5 years ago.
COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

COVH has an Altman-Z score of 1.02. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COVH (1.02) is better than 67.50% of its industry peers.
The Debt to FCF ratio of COVH is 12.72, which is on the high side as it means it would take COVH, 12.72 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COVH (12.72) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
COVH's Debt to Equity ratio of 0.70 is in line compared to the rest of the industry. COVH outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Altman-Z 1.02
ROIC/WACC0.68
WACC5.4%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.16, COVH belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH's Quick ratio of 1.16 is amongst the best of the industry. COVH outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 241.67%, which is quite impressive.
COVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.16% yearly.
Looking at the last year, COVH shows a decrease in Revenue. The Revenue has decreased by -5.26% in the last year.
Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.29% on average per year.
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

COVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.
The Revenue is expected to grow by 0.55% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.96, the valuation of COVH can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of COVH is on the same level as its industry peers.
COVH is valuated rather cheaply when we compare the Price/Earnings ratio to 26.76, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.57, which indicates a correct valuation of COVH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH indicates a slightly more expensive valuation: COVH is more expensive than 65.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of COVH to the average of the S&P500 Index (22.63), we can say COVH is valued slightly cheaper.
Industry RankSector Rank
PE 16.96
Fwd PE 13.57
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COVH's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, COVH is valued a bit more expensive than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.99
EV/EBITDA 16.92
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.63
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.25%, COVH is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.85, COVH pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.25%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

19.16% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP19.16%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (10/29/2025, 7:00:00 PM)

23.4

+0.4 (+1.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.70B
Revenue(TTM)260.60M
Net Income(TTM)205.77M
Analysts82.86
Price Target18.67 (-20.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.25%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.16%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.96
Fwd PE 13.57
P/S 14.19
P/FCF 15.99
P/OCF 10.11
P/B 1.06
P/tB 1.17
EV/EBITDA 16.92
EPS(TTM)1.38
EY5.9%
EPS(NY)1.72
Fwd EY7.37%
FCF(TTM)1.46
FCFY6.26%
OCF(TTM)2.31
OCFY9.89%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.63
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.74%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Debt/EBITDA 6.97
Cap/Depr 152.56%
Cap/Sales 51.52%
Interest Coverage 4.11
Cash Conversion 103.65%
Profit Quality 112.39%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.02
F-Score5
WACC5.4%
ROIC/WACC0.68
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.29%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


Can you provide the valuation status for COVIVIO HOTELS SACA?

ChartMill assigns a valuation rating of 2 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


How financially healthy is COVIVIO HOTELS SACA?

The financial health rating of COVIVIO HOTELS SACA (COVH.PA) is 4 / 10.


Is the dividend of COVIVIO HOTELS SACA sustainable?

The dividend rating of COVIVIO HOTELS SACA (COVH.PA) is 6 / 10 and the dividend payout ratio is 19.16%.